Ryan D. Maynard
Director · IOVANCE BIOTHERAPEUTICS, INC.
IndividualSelling only
- 2024
- Jun 18, 2026
- 3
Other insiders active in the same sector
No other insider has filed at Ryan D. Maynard's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ryan D. Maynard?
Ryan D. Maynard is a corporate insider, tracked as Director of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Ryan D. Maynard last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 3 filings going back to 2024.
Has Ryan D. Maynard been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($503K) across all tracked filings.
